Department of Molecular and Clinical medicine, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Public Health Promotion Unit, National Institute for Health and Welfare, Helsinki, Finland.
PLoS One. 2021 Mar 25;16(3):e0248550. doi: 10.1371/journal.pone.0248550. eCollection 2021.
Bariatric surgery in patients with obesity is generally considered to reduce cancer risk in patients with obesity. However, for colorectal cancer some studies report an increased risk with bariatric surgery, whereas others report a decreased risk. These conflicting results demonstrate the need of more long-term studies analyzing the effect of bariatric surgery on colorectal cancer risk. Therefore, data from the Swedish Obese Subjects (SOS) study, ClinicalTrials.gov identifier: NCT01479452, was used to examine the impact of bariatric surgery on long-term incidence of colorectal cancer. The SOS study includes 2007 patients who underwent bariatric surgery and 2040 contemporaneously matched controls who received conventional obesity treatment. Patients in the surgery group underwent gastric bypass (n = 266), banding (n = 376) or vertical banded gastroplasty (n = 1365). Information on colorectal cancer events was obtained from the Swedish National Cancer Registry. Median follow-up was 22.2 years (inter-quartile range 18.3-25.2). During follow up there were 58 colorectal cancer events in the surgery group and 67 colorectal cancer events in the matched control group with a hazard ratio (HR) of 0.79 (95% CI:0.55-1.12; p = 0.183). After adjusting for age, body mass index, alcohol intake, smoking status, and diabetes, the adjusted HR was 0.89 (95% CI:0.62-1.29; p = 0.551). When analyzing rectal cancer events separately- 19 events in the surgery group and 31 events in the control group-a decreased risk of rectal cancer with surgery was observed (HR = 0.56; 95% CI:0.32-0.99; p = 0.045, adjusted HR = 0.61 (95% CI:0.34-1.10; p = 0.099), while the risk of colon cancer was unchanged. To conclude- in this long-term, prospective study, bariatric surgery was not associated with altered colorectal cancer risk.
肥胖患者的减肥手术通常被认为可以降低肥胖患者的癌症风险。然而,对于结直肠癌,一些研究报告减肥手术会增加风险,而另一些研究则报告风险降低。这些相互矛盾的结果表明,需要更多的长期研究来分析减肥手术对结直肠癌风险的影响。因此,使用来自瑞典肥胖受试者(SOS)研究的数据,ClinicalTrials.gov 标识符:NCT01479452,来研究减肥手术对长期结直肠癌发病率的影响。SOS 研究包括 2007 名接受减肥手术的患者和 2040 名同期接受常规肥胖治疗的匹配对照者。手术组患者接受胃旁路手术(n = 266)、带术(n = 376)或垂直带胃成形术(n = 1365)。结直肠癌事件的信息来自瑞典国家癌症登记处。中位随访时间为 22.2 年(四分位距 18.3-25.2)。随访期间,手术组有 58 例结直肠癌事件,匹配对照组有 67 例结直肠癌事件,风险比(HR)为 0.79(95%CI:0.55-1.12;p = 0.183)。调整年龄、体重指数、饮酒、吸烟状况和糖尿病后,调整后的 HR 为 0.89(95%CI:0.62-1.29;p = 0.551)。单独分析直肠癌事件时-手术组有 19 例,对照组有 31 例-观察到手术降低直肠癌风险(HR = 0.56;95%CI:0.32-0.99;p = 0.045,调整后的 HR = 0.61(95%CI:0.34-1.10;p = 0.099),而结肠癌风险无变化。总之-在这项长期前瞻性研究中,减肥手术与结直肠癌风险改变无关。